Three bufadienolides induce cell death in the human lung cancer cell line CL1-5 mainly through autophagy

Bioorg Med Chem Lett. 2021 Jan 1:31:127715. doi: 10.1016/j.bmcl.2020.127715. Epub 2020 Nov 25.

Abstract

The effects of 3 bufadienolides, namely kalantuboside B, kalantuboside A, and bryotoxin C, isolated from Kalanchoe tubiflora (Harvey) were evaluated and characterized in CL1-5 highly metastatic human lung cancer cells. In contrast to their apoptosis-promoting activity in other cancer cells, these bufadienolides only slight or did not induce apoptosis in CL1-5 cancer cells. Instead, they activated an autophagy pathway, as indicated by increased autophagosome formation. Autophagy induced by these bufadienolides was demonstrated to be linked to the down-regulation of p-mTOR and the up-regulation of LC3-II, ATG5, ATG7, and Beclin-1. Our findings revealed an autophagy as the alternative mechanism of drug action by bufadienolides in CL1-5 lung cancer cells and provided evidence that bufadienolides are a potential therapeutic strategy for highly metastatic human lung cancer.

Keywords: Autophagy; CL1-5 human lung cancer cells; Kalanchoe tubiflora.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Autophagy / drug effects*
  • Bufanolides / chemical synthesis
  • Bufanolides / chemistry
  • Bufanolides / pharmacology*
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Conformation
  • Molecular Docking Simulation
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Bufanolides